Premier Biomedical, Inc.
BIEI
$0.0004
-$0.0002-33.33%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -131.22% | -142.06% | 89.40% |
| Total Depreciation and Amortization | -- | -- | 4.17% | -4.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -21.11% | 22.31% | 7.54% |
| Total Other Non-Cash Items | -- | -- | 110.01% | 108.38% | -110.30% |
| Change in Net Operating Assets | -- | -- | -145.45% | -284.22% | -1,106.96% |
| Cash from Operations | -- | -- | -21.39% | 1.25% | 12.28% |
| Capital Expenditure | -- | -- | -145.00% | 40.43% | 25.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -5,000.00% | -7.69% | 25.93% |
| Total Debt Issued | -- | -- | -14.29% | -15.28% | 0.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 112.41% | 37.84% | -21.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 166.70% | 101.53% | -94.94% |
